Literature DB >> 12435166

Expanding role of biologic agents in rheumatoid arthritis.

Joachim R Kalden1.   

Abstract

Biologic agents are an important addition to the therapeutic armamentarium for rheumatoid arthritis (RA). Initially these drugs were reserved for use in patients with progressive RA who had an inadequate response to treatment with disease modifying antirheumatic drugs. The optimal role of biologics in the treatment of RA remains to be defined. Data from ongoing clinical trials will provide insight on when to most effectively administer these agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435166

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  3 in total

1.  Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.

Authors:  F C Breedveld; C Han; M Bala; D van der Heijde; D Baker; A F Kavanaugh; R N Maini; P E Lipsky
Journal:  Ann Rheum Dis       Date:  2004-07-29       Impact factor: 19.103

2.  Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis.

Authors:  Cynthia Said; Bernard Coleiro; Maurice Zarb Adami; Lilian M Azzopardi; Anthony Serracino Inglott
Journal:  Int J Inflam       Date:  2013-11-13

3.  Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept.

Authors:  Ahmad Gholami; Jassem Azizpoor; Elham Aflaki; Mehdi Rezaee; Khosro Keshavarz
Journal:  Biomed Res Int       Date:  2021-11-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.